Skip to content

The applicability of fieldable and rapid serological and molecular testing for Corona SARS-2 in a Dutch population during the COVID-19 outbreak- a pilot study

The applicability of fieldable and rapid serological and molecular testing for Corona SARS-2 in a Dutch population during the COVID-19 outbreak- a pilot study - Research on performance fieldable point of care diagnostics Corona SARS-2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49054
Enrollment
369
Registered
2020-06-22
Start date
2020-06-26
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona Sars CoV-2 COVID-19

Interventions

None listed

Sponsors

Ministerie van Defensie,
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Group 1 • Complete set samples available as complete set from persons being samples before the outbreak of COVID -19 (

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Obtaining knowledge on the performance of fieldable point of care testen: will they provide reliable information on viral replication intermediars of virusparticles and antigens. Decision making on which type of body fluid will generate the best results

Secondary

MeasureTime frame
IIs the test applicable under field circumstances lacking well equiped laboratory facilities.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)